These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34014055)

  • 1. Health Care Provider Perceptions of Facilitators and Barriers to Human Papillomavirus Vaccination Delivery in Five Countries.
    Islam JY; Gurbani A; Ramos S; Morgan K; Kim CJ; Richter KL; de Sanjose S; Smith JS; Vielot NA
    Sex Transm Dis; 2021 Aug; 48(8):557-564. PubMed ID: 34014055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV Vaccination Recommendation Practices among Adolescent Health Care Providers in 5 Countries.
    Topazian HM; Kundu D; Peebles K; Ramos S; Morgan K; Kim CJ; Richter KL; Brewer NT; Peris M; Smith JS
    J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):575-582.e2. PubMed ID: 30017958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescent providers' knowledge of human papillomavirus vaccination age guidelines in five countries.
    Topazian HM; Dizon AM; Di Bona VL; Levitz L; Ramos S; Morgan K; Kim CJ; Richter K; De Sanjose S; Smith JS
    Hum Vaccin Immunother; 2019; 15(7-8):1672-1677. PubMed ID: 30625017
    [No Abstract]   [Full Text] [Related]  

  • 4. Acceptability of two- versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries.
    Islam JY; Hoyt AM; Ramos S; Morgan K; Kim CJ; de Sanjose S; Butera N; Senkomago V; Richter KL; McDonald MA; Vielot NA; Smith JS
    Cancer Causes Control; 2018 Nov; 29(11):1115-1130. PubMed ID: 30284670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.
    Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S
    Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persuasive messaging for human papillomavirus vaccination by adolescent providers in a five-country multi-site study.
    Rwamwejo J; Ramos S; Morgan K; Richter K; Kim CJ; Peris M; Smith JS
    Int J Gynecol Cancer; 2019 Feb; 29(2):250-256. PubMed ID: 30718309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative descriptive study of providers' perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators.
    Morales-Campos DY; Flores BE; Donovan E; Burdick S; Parra-Medina D; Kahn JA
    BMC Public Health; 2022 Mar; 22(1):443. PubMed ID: 35248000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
    Glenn BA; Nonzee NJ; Tieu L; Pedone B; Cowgill BO; Bastani R
    Vaccine; 2021 Jun; 39(25):3435-3444. PubMed ID: 33992435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stakeholders' perspectives on system-level barriers to and facilitators of HPV vaccination among Hispanic migrant farmworkers.
    Vamos CA; Kline N; Vázquez-Otero C; Lockhart EA; Lake PW; Wells KJ; Proctor S; Meade CD; Daley EM
    Ethn Health; 2022 Aug; 27(6):1442-1464. PubMed ID: 33733962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
    Lim ASE; Lim RBT
    Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?
    Amponsah-Dacosta E; Blose N; Nkwinika VV; Chepkurui V
    Front Public Health; 2022; 10():799984. PubMed ID: 35174123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of Parent's awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention.
    Sitaresmi MN; Rozanti NM; Simangunsong LB; Wahab A
    BMC Public Health; 2020 Dec; 20(1):1836. PubMed ID: 33256697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Mixed-Methods Analysis of Barriers to and Facilitators of Human Papillomavirus Vaccination Among Adolescents in Montana.
    Newcomer SR; Caringi J; Jones B; Coyle E; Schehl T; Daley MF
    Public Health Rep; 2020; 135(6):842-850. PubMed ID: 32972304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.
    Vadaparampil ST; Staras SA; Malo TL; Eddleton KZ; Christie J; Rodriguez M; Giuliano AR; Shenkman EA
    Cancer; 2013 Feb; 119(3):621-8. PubMed ID: 23341308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Papillomavirus Vaccine Uptake: Increase for American Indian Adolescents, 2013-2015.
    Jacobs-Wingo JL; Jim CC; Groom AV
    Am J Prev Med; 2017 Aug; 53(2):162-168. PubMed ID: 28256284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives.
    Yared N; Malone M; Welo E; Mohammed I; Groene E; Flory M; Basta NE; Horvath KJ; Kulasingam S
    Cancer Causes Control; 2021 Oct; 32(10):1107-1116. PubMed ID: 34247291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge of HPV vaccination uptake and opportunities for solutions: Lessons learned from Alabama.
    Dilley SE; Peral S; Straughn JM; Scarinci IC
    Prev Med; 2018 Aug; 113():124-131. PubMed ID: 29800594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review.
    Zheng L; Wu J; Zheng M
    Sex Transm Dis; 2021 Dec; 48(12):e255-e262. PubMed ID: 33783412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misinformation Drives Low Human Papillomavirus Vaccination Coverage in South African Girls Attending Private Schools.
    Milondzo T; Meyer JC; Dochez C; Burnett RJ
    Front Public Health; 2021; 9():598625. PubMed ID: 33681125
    [No Abstract]   [Full Text] [Related]  

  • 20. Why don't adolescents finish the HPV vaccine series? A qualitative study of parents and providers.
    Perkins RB; Chigurupati NL; Apte G; Vercruysse J; Wall-Haas C; Rosenquist A; Lee L; Clark JA; Pierre-Joseph N
    Hum Vaccin Immunother; 2016 Jun; 12(6):1528-35. PubMed ID: 26810765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.